In December 2020, the US Food and Drug Administration (FDA) approved labeling changes stating that Januvia (sitagliptin), Janumet (sitagliptin and metformin hydrochloride), and Janumet XR (sitagliptin and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in children aged 10 to 17 with type 2 diabetes
On the other hand, some concerns to think about for older adults taking GLP-1s include: Dehydration
Same thing with, with the ultra processed food designation, long ingredients list, ingredients that you can't pronounce doesn't necessarily make it an ultra processed food, but you could almost like, you know, it's, it's a, the odds are good
Note: The risk-benefit equation of intensive glycemic control may progressively shift in favor of less-intensive control as diabetes progresses
Since patient downtime is minimal, makeup can be applied 1 to 2 days after the treatment
Four weeks per step is a guide, not a deadline